<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003787" GROUP_ID="MUSKEL" ID="672901081313524011" MERGED_FROM="" MODIFIED="2010-05-25 16:04:21 -0400" MODIFIED_BY="Michelle Foote" REVIEW_NO="C088-R" REVMAN_SUB_VERSION="5.0.24" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2010-05-25 16:04:21 -0400" MODIFIED_BY="Michelle Foote">
<TITLE>Therapeutic ultrasound for the treatment of rheumatoid arthritis</TITLE>
<CONTACT>
<PERSON ID="14913" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Lynn</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Casimiro</LAST_NAME>
<SUFFIX/>
<POSITION>Full Time Lecturer</POSITION>
<EMAIL_1>casimiro@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL>www.uottawa.ca</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext: 8129</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2010-05-25 16:04:21 -0400" MODIFIED_BY="Michelle Foote">
<PERSON ID="14913" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Lynn</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Casimiro</LAST_NAME>
<SUFFIX/>
<POSITION>Full Time Lecturer</POSITION>
<EMAIL_1>casimiro@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL>www.uottawa.ca</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext: 8129</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="9058" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Lucie</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Brosseau</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>Lucie.Brosseau@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613-562-5800 ext: 8015</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="13312" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Vivian</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Welch</LAST_NAME>
<SUFFIX/>
<POSITION>Research Associate</POSITION>
<EMAIL_1>vivian.welch@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Centre for Global Health, Institute of Population Health</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>1 Stewart Street, Room 206</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562-5800 ext: 2921</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613 562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14968" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Sarah</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Milne</LAST_NAME>
<SUFFIX/>
<POSITION>Physiotherapist</POSITION>
<EMAIL_1>smiln080@uottawa.ca</EMAIL_1>
<EMAIL_2>sarahmilne23@hotmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Rehabilitation Center</DEPARTMENT>
<ORGANISATION>Children's Hospital of Eastern Ontario</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP/>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-737-7600 ext: 2778</PHONE_1>
<PHONE_2/>
<FAX_1>613-738-4232</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7D89FCA582E26AA20029B854A42545FC" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Maria</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Judd</LAST_NAME>
<SUFFIX>MSc</SUFFIX>
<POSITION>Senior Program Officer</POSITION>
<EMAIL_1>maria.judd@chsrf.ca</EMAIL_1>
<EMAIL_2>mgjudd@yahoo.ca</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Research Use/Agente principale de programme, Utilisation de la Recherche</DEPARTMENT>
<ORGANISATION>Canadian Health Services Research Foundation/Fondation canadienne de la recherche sur les services de santé</ORGANISATION>
<ADDRESS_1>1565 avenue Carling Avenue</ADDRESS_1>
<ADDRESS_2>Suite/pièce 700</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1Z 8R1</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-728-2238 ext/poste 250</PHONE_1>
<PHONE_2/>
<FAX_1>613-728-3527</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12662" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>George</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Wells</LAST_NAME>
<SUFFIX>PhD, MSc</SUFFIX>
<POSITION>Director</POSITION>
<EMAIL_1>gawells@ottawaheart.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cardiovascular Research Reference Centre</DEPARTMENT>
<ORGANISATION>University of Ottawa Heart Institute</ORGANISATION>
<ADDRESS_1>Room H1-1</ADDRESS_1>
<ADDRESS_2>40 Ruskin Street</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1Y 4W7</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 798 5555 x18640</PHONE_1>
<PHONE_2>+1 613 798 5555 x18642</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5474" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Tugwell</LAST_NAME>
<SUFFIX/>
<POSITION>Director</POSITION>
<EMAIL_1>elacasse@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Centre for Global Health, Institute of Population Health, Department of Medicine</DEPARTMENT>
<ORGANISATION>Ottawa Hospital</ORGANISATION>
<ADDRESS_1>1 Stewart Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext: 1945</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5440" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Beverley</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Shea</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>bevshea@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institute of Population Health</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>1 Stewart St.</ADDRESS_1>
<ADDRESS_2>Room 312</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562 5800 ext: 8571</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-09 15:51:14 -0500" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="29" MONTH="4" YEAR="2002"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="29" MONTH="4" YEAR="2002"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="11" YEAR="2008"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="" YEAR=""/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2002"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2002"/>
</DATES>
<WHATS_NEW MODIFIED="2008-11-09 15:51:36 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-09 15:51:36 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
<P>CMSG ID: C088-R</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-11-09 15:52:10 -0500" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Ottawa Health Research Institute</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Ottawa</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Institute of Population Health</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-09 15:54:37 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY>
<TITLE>Continuous ultrasound to the hand benefits grip strength in people with rheumatoid arthritis (RA)</TITLE>
<SUMMARY_BODY>
<P>Ultrasound is one of the modalities often chosen by qualified health professionals for the symptomatic treatment of RA based on its anti-inflammatory and analgesic effects. This review of two randomized trials (RCTs) showed that continuous ultrasound applied in water to the dorsal and palmar aspects of the hand increased grip strength as compared with placebo. This benefit was not evident with combined therapy (exercise, wax bath, faradic hand baths). Ultrasound also produced a borderline increase in wrist dorsal flexion, decreased morning stiffness, and reduced the number of swollen and painful joints. The conclusions are limited by few studies, small sample size and limitations in study methodology.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Ultrasound is often used by rehabilitation specialists as an adjunct therapy for the symptomatic treatment of rheumatoid arthritis (RA). Its mechanical energy has anti-inflammatory as well as analgesic properties. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To evaluate the effects of ultrasound on objective and subjective measures of disease activity in people with RA.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>A comprehensive search was conducted of the Cochrane Field of Rehabilitation and Related Therapies register, Cochrane Musculoskeletal Review Group register, MEDLINE, EMBASE, PEDro, Current Contents, Sports Discus, and CINAHL (to September 2001). Handsearching was conducted on all retrieved papers and content experts were contacted to identify additional studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Comparative controlled studies including randomized controlled trials and clinical controlled trials in people with RA were eligible. No language restrictions were applied. Abstracts were accepted. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two independent reviewers identified potential articles from the literature search. These reviewers extracted data using pre-defined extraction forms. Consensus was reached on all the extracted data. Quality was assessed by two reviewers using a five point validated assessment tool that measured the quality of randomization, double-blinding and description of withdrawals.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Two studies (n of 80), where n is the number of participants, met the inclusion criteria. Ultrasound to the palmar and dorsal aspects of the hand significantly increased grip strength, measured as weighted mean difference (WMD) from control [WMD 28.07 (95 CI: 13.37 to 42.77)]. Ultrasound to the palmar and dorsal aspects of the hand also appeared to have beneficial effects on the following outcome measures: wrist dorsal flexion [WMD 1.90 (95%CI: 0.64 to 3.16)], duration of morning stiffness [WMD 28.54 (95%CI: 0.18 to 56.90)], number of swollen joints [WMD 1.02 (95%CI: 0.45 to 1.59)], and the number of painful joints [WMD 1.20 (95%CI: 0.45 to 1.95)]. There was no significant difference between a) exercises and wax baths, b) exercises with ultrasound, c) exercises with ultrasound and faradic hand baths on the outcome measures: pain score, grip strength, circumference of proximal interphalangeal (PIP) joints, articular index, and range of motion or level of activity.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>The reviewers concluded that ultrasound in combination with exercises, faradic current and wax bath treatment modalities is not supported and cannot be recommended. Ultrasound alone can, however, be used on the hand to increase grip strength, and to a lesser extent and based on borderline results, increase wrist dorsal flexion, decrease morning stiffness, reduce the number of swollen joints, and reduce the number of painful joints. It is important to note that these conclusions are limited by methodological considerations such as poor quality of the included trials, the low number of clinical trials, and the small number of study participants.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-09 15:54:37 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>The physiological effects of therapeutic ultrasound are well documented (<LINK REF="REF-Health-Canada-1987" TYPE="REFERENCE">Health Canada 1987</LINK>). These physiological effects can be summed up by the following explanation. Pulsed or continuous ultrasound increases cell permeability by setting up cavitation thus aiding cell communication across articular membranes and linings; this mechanical effect explains the anti-inflammatory properties of ultrasound. Stable cavitation also reduces the nerve conduction velocity of C fibers, thus decreasing pain. Ultrasound can increase intra tissue temperature when used in a continuous mode. One of the benefits of these ultrasound thermal effects is the reduction of muscle spindle activity and consequently the reduction of muscle spasms and pain. </P>
<P>Despite the documented biological effects of ultrasound on tissues, it is not one of the most frequently used modalities in the symptomatic treatment of RA patients and therefore not the most frequently studied. Furthermore, texts on patient management do not purport the use of ultrasound due to the lack of scientific evidence to date (<LINK REF="REF-Helewa-1996" TYPE="REFERENCE">Helewa 1996</LINK>, <LINK REF="REF-Lineker-1999" TYPE="REFERENCE">Lineker 1999</LINK>, <LINK REF="REF-Walker-1996" TYPE="REFERENCE">Walker 1996</LINK>). In fact, the Philadelphia panel found insufficient data to be able to develop Evidence Based Clinical Practice Guidelines (EBCPGs) for several conditions, including RA (<LINK REF="REF-Philadelphia-2001" TYPE="REFERENCE">Philadelphia 2001</LINK>).</P>
<P>From a practical point of view, ultrasound cannot be applied at home by the individual and requires the consultation of a regulated healthcare professional. Since one of the major components of RA management is self-care and empowerment (<LINK REF="REF-Lineker-1999" TYPE="REFERENCE">Lineker 1999</LINK>), ultrasound does not fit well into this treatment approach. Nonetheless, there are several potentially beneficial physiological and clinical effects of ultrasound therapy for people with RA that are worth exploring.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To evaluate the efficacy of ultrasound therapy for the relief of signs and symptoms of people with RA as compared to placebo and other treatment interventions.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-09 15:54:37 -0500" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>According to an a priori protocol, all comparative controlled trials, randomized controlled trials (RCT) and controlled clinical trials without randomization (CCT) were included because studies on efficacy of ultrasound therapy are rare. Trials which used participants as their own control were not accepted. The results were graded according to the strength of the study design.</P>
<P>No language limitations were imposed. Abstracts were accepted.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Adults with classic or definite rheumatoid arthritis (<LINK REF="REF-BMJ-2001" TYPE="REFERENCE">BMJ 2001</LINK>) treated with ultrasound on any joint except the spine.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Acceptable interventions included ultrasound applications using any combination of parameters. For example, intensity, mode, or size of the ultrasound head were not discriminated between with regard to the inclusion criteria.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>The primary outcome measure was pain. All secondary outcome measures were from the potential core set identified by the OMERACT conference on rheumatoid arthritis outcomes (<LINK REF="REF-OMERACT-1993" TYPE="REFERENCE">OMERACT 1993</LINK>), including:</P>
<P>Number of tender joints per patient;<BR/>Number of swollen joints per patient;<BR/>Physician global assessment;<BR/>Patient global assessment;<BR/>Functional status;<BR/>Range of motion (ROM);<BR/>Strength.</P>
<P>Physiological outcomes such as skin and joint temperature were not included in the analysis.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-09 15:54:37 -0500" MODIFIED_BY="[Empty name]">
<P>The literature search was conducted according to the sensitive search strategy for RCTs designed for the Cochrane Collaboration (<LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>), with modifications proposed by <LINK REF="REF-Haynes-1994" TYPE="REFERENCE">Haynes 1994</LINK>. Additional terms for the study design, used to identify observational studies, included: case-control, cohort, comparative study, clinical trial. The Cochrane Musculoskeletal Review Group register, Cochrane Field of Physical and Related Therapies register, MEDLINE, EMBASE, HealthSTAR, Sports Discus, and CINAHL (to September 2001) were searched using a keyword and text word search strategy (shown in Appendix 1). In addition, the reference lists of included trials were searched and content experts were contacted for additional studies.</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>Two independent reviewers (VR, LB) examined the titles and abstracts of the trials identified by the search strategy to select trials that met the inclusion criteria. All trials classified as relevant by at least one of the reviewers were retrieved. The retrieved articles were re-examined to ensure they met the inclusion criteria and were assessed for quality. The results of the individual trials were extracted from each of the included trials by two independent reviewers (LB, VR) using pre-determined extraction forms. The data was cross-checked by a third reviewer (BS). The extraction forms were developed and pilot-tested based on other forms used by the Cochrane Musculoskeletal Review Group. The extraction form also documented specific information about ultrasound therapy. The final data values were based on consensus of the two reviewers. </P>
<P>Statistical Analysis: Most outcomes were continuous in nature (ROM, pain, and strength). Pooling of data from the two included trials was not possible. </P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>The literature search and handsearching identified eight potential articles. Of these, two RCT studies were included and involved 80 RA participants (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>, <LINK REF="STD-Konrad-1994" TYPE="STUDY">Konrad 1994</LINK>). The first included study (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>) examined ultrasound combined with exercises, ultrasound coupled with faradic (electric) current, ultrasound coupled with faradic current and exercises, and ultrasound combined with wax baths, for its effects on grip strength, circumference of proximal interphalangeal (PIP) joints, articular index, pain score, range of motion, and level of activity. The second included study (<LINK REF="STD-Konrad-1994" TYPE="STUDY">Konrad 1994</LINK>) examined ultrasound compared to a control group for its effects on PIP circumference, grip strength, wrist dorsal flexion, duration of morning stiffness, number of swollen joints, and the number of painful joints.</P>
<P>Six trials were excluded for several reasons: <LINK REF="STD-Berliner-1997" TYPE="STUDY">Berliner 1997</LINK> was a study with healthy participants; <LINK REF="STD-Bromley-1994" TYPE="STUDY">Bromley 1994</LINK> used a mixed population of healthy and RA participants; <LINK REF="STD-El_x002d_Hadidi-1991" TYPE="STUDY">El-Hadidi 1991</LINK> measured the effects of medication; <LINK REF="STD-Herrera_x002d_Lasso-1993" TYPE="STUDY">Herrera-Lasso 1993</LINK> did not include RA participants; <LINK REF="STD-Kitchen-1990" TYPE="STUDY">Kitchen 1990</LINK> was a literature review; <LINK REF="STD-Nykanen-1995" TYPE="STUDY">Nykanen 1995</LINK> did not mention the inclusion of RA participants. </P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>Methodological quality was assessed using a validated checklist (<LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>). The components of quality focused on randomization, double-blinding, and description of withdrawals. Two independent reviewers (LB, VR) assessed quality and differences were resolved by discussion with a third reviewer (BS). Quality was to be used in subgroup analyses to test the hypothesis that poorly conducted trials demonstrate greater efficacy of the intervention under evaluation. Each item (i.e. randomization, blinding, and withdrawals) was examined separately for its effects. Studies were also assessed and rated based on allocation concealment of participants to treatment or control groups.</P>
<P>The median methodological quality of these seven RCTs was 2, with a range from 1 to 3. None scored full points for randomization, none scored full points for double-blinding. Only the <LINK REF="STD-Konrad-1994" TYPE="STUDY">Konrad 1994</LINK> study was double-blind.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>Two trials were included in this review. Only one, however, showed positive results for the use of ultrasound on symptomatic RA, on the hands (<LINK REF="STD-Konrad-1994" TYPE="STUDY">Konrad 1994</LINK>). The results of the two studies could not be combined in a meta-analysis and hence are presented separately. </P>
<P>In the first study (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>), three treatment groups were compared: a) exercises and wax bath, b) exercises with ultrasound, c) exercises with ultrasound and faradic hand baths. The ultrasound was applied in water to the palmar aspect of the hand, at 0.250 W/cm2 with a constant beam of 3 MHz. The ultrasound treatment regimen was three minutes, five times a week, for three weeks. No significant difference was found between groups with regard to pain score, grip strength, circumference of proximal interphalangeal (PIP) joints, articular index, range of motion, or level of activity. </P>
<P> In the second study (<LINK REF="STD-Konrad-1994" TYPE="STUDY">Konrad 1994</LINK>), ultrasound treatment was compared with a placebo ultrasound control group. The ultrasound was applied in water to the dorsal and palmar aspects of the hand, at 0.05 W/cm2 continuously using a circular round head. The treatment regimen lasted ten minutes, on alternate days, for three weeks, for a total of 10 sessions. A clearly significant increase in grip strength was found in the treatment (ultrasound) group compared with placebo, expressed as weighted mean difference (WMD) [WMD 28.07 (95% CI: 13.37 to 42.77)]. Furthermore, a significant difference in favour of the treatment group was reported for wrist dorsal flexion [WMD 1.90 (95% CI: 0.64 to 3.16)], duration of morning stiffness [WMD 28.54 (95% CI: 0.18 to 56.90)], number of swollen joints [WMD 1.02 (95% CI: 0.45 to 1.59)], and number of painful joints [WMD 1.20 (95% CI: 0.45 to 1.95)]. Ultrasound was not found to significantly decrease PIP circumference.</P>
<P>No harmful side effects were reported.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>The first study (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>) ) found no significant difference using ultrasound with regard to pain score, grip strength, circumference of PIP joints, articular index, range of motion, or level of activity when comparing three groups of treatment interventions: a) exercises and wax bath, b) exercises with ultrasound, c) exercises with ultrasound and faradic hand baths. In this study, the total number of visits and type of ultrasound head were not recorded. The comparison of three treatment groups with no placebo controls made the results very difficult to interpret. Furthermore, ultrasound treatment was always combined with another treatment, further confounding the effect of the ultrasound application. Even though it reflects common clinical practice in physiotherapy, these combined interventions introduce biases and the specific efficacy of a single intervention for RA cannot be isolated. For example, endorphin and enkephalin production is stimulated by exercises (<LINK REF="REF-Coutts-1994" TYPE="REFERENCE">Coutts 1994</LINK>) and may reduce arthritic pain as effectively as, but not additional to, ultrasound. Combining ultrasound with a wax bath may enhance or diminish the effect of either one alone.</P>
<P>In the second trial, <LINK REF="STD-Konrad-1994" TYPE="STUDY">Konrad 1994</LINK> found significant differences between ultrasound application and a placebo control group. Ultrasound on the dorsal and palmar aspects of the hand clearly increased grip strength. One should question, however, whether this benefit is long term. The effects of ultrasound on the duration of morning stiffness, number of swollen joint, number of painful joints, and on the degree of wrist dorsal flexion were also significant, although of borderline statistical significance. The ultrasound treatment protocol included all necessary parameters needed to replicate the ultrasound application except for the size of the ultrasound head (MHz).</P>
<P>In both the <LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK> and the <LINK REF="STD-Konrad-1994" TYPE="STUDY">Konrad 1994</LINK> studies continuous ultrasound waves were used. This choice is supported by the documented physiological effects of ultrasound (<LINK REF="REF-Health-Canada-1987" TYPE="REFERENCE">Health Canada 1987</LINK>), both pulsed and continuous ultrasound, to increase cell permeability and exert an anti-inflammatory action. Furthermore, both pulsed and continuous ultrasound reduce the nerve conduction velocity of pain nerve fibers. Continuous ultrasound additionally has thermal effects which reduce muscle spasms and pain. The thermal effects also cause vasodilation (expansion of blood vessels), which helps the excretion of chemicals produced by inflammatory cells in a chronic condition. Despite the documented physiological effects of ultrasound on tissues, only one study (<LINK REF="STD-Konrad-1994" TYPE="STUDY">Konrad 1994</LINK>) showed a clearly significant result on grip strength. Perhaps the clinical outcome measures used in the included studies were not sensitive enough to accurately record the physiological effects.</P>
<P>Recent guidelines by the Philadelphia Panel (<LINK REF="REF-Philadelphia-2001" TYPE="REFERENCE">Philadelphia 2001</LINK>) concluded there was insufficient evidence to make a recommendation regarding ultrasound for knee RA. Similarly, a recent systematic review (<LINK REF="REF-Puett-1994" TYPE="REFERENCE">Puett 1994</LINK>) for OA of the knee was unable to draw conclusions regarding ultrasound, due to a lack of evidence. The <LINK REF="REF-ACR-1996" TYPE="REFERENCE">ACR 1996</LINK>, <LINK REF="REF-BMJ-2001" TYPE="REFERENCE">BMJ 2001</LINK> and the <LINK REF="REF-Manal-1996" TYPE="REFERENCE">Manal 1996</LINK> guidelines do not make recommendations regarding ultrasound for RA.</P>
<P>Confounding variables such as characteristics of the therapeutic application, characteristics of the population, characteristics of the disease state, and methodological considerations, may have contributed to the borderline effects found with ultrasound (<LINK REF="REF-Morin-1996" TYPE="REFERENCE">Morin 1996</LINK>). Population characteristics of importance include age, gender, disease duration (acute or chronic), and post-surgery compared with non-surgical. It is crucial that details on all these characteristics be addressed in studies of ultrasound and that they are reported consistently in published studies.</P>
<P>Several methodological issues may have impacted on the results of the two included studies. Most of these methodological issues are related to either study design or the reporting of trial results. The following issues, related to study design, could be addressed in future studies: randomization method, sample size, study duration, and selection of outcome measures. The development of a standardized set of validated outcome measures such as those recommended by OMERACT (<LINK REF="REF-OMERACT-1993" TYPE="REFERENCE">OMERACT 1993</LINK>) would help improve the quality of studies and facilitate pooling data in meta-analyses. Reporting of data should be standardized in RCTs and mean and standard deviation of every outcome should be systematically provided in trial results. </P>
<P>The problem of lack of participant blinding in the study by <LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK> is common to trials of rehabilitation interventions (<LINK REF="REF-Deyo-1990" TYPE="REFERENCE">Deyo 1990</LINK>). <BR/>Due to the nature of many rehabilitation interventions, participant blinding is not always feasible.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Ultrasound in combination with the following treatment modalities: exercises, faradic current, and wax baths is not supported and cannot be recommended. Ultrasound alone can, however, be used on the hand to increase grip strength, and to a lesser extent and based on borderline results, increase wrist dorsal flexion, decrease morning stiffness, and reduce the number of swollen and painful joints. No harmful side effects were reported with ultrasound treatment. It is important to note that these conclusions are limited by the methodological considerations of poor quality of the trials, the low number of clinical trials (two), and the small sample size of the included studies.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>More sensitive, valid, and standardized clinical outcomes should be used in studies on the use of ultrasound to reflect the physiological effects reported in the scientific literature. Research investigating the optimal characteristics of the therapeutic application of ultrasound on different human RA joints is needed.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>The authors wish to thank Jessie McGowan, Catherine Lamothe and Shannon Rees for their indispensable contributions.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>This review was initially conducted as part of a guidelines development project which received support from an educational grant with unrestricted conditions from the CIGNA Foundation, a health insurance company in the USA. The CIGNA Foundation had no rights of authorship or publication. This final review was completed with the support of a research grant obtained from the Arthritis Society (CANADA).</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>VR extracted and analyzed data and selected trials of the initial review.</P>
<P>LB contributed data extraction, update of the selection of the reference list, update of the analyses and update of the interpretation of results .</P>
<P>LC was responsible for writing the manuscript, contributed data extraction, update of the analyses and interpretation of results.</P>
<P>BS checked quality and data extraction and contributed methodological expertise and commented on early drafts.</P>
<P>GW and PT contributed methodological expertise and commented on early drafts.</P>
<P>MJ provided feedback and editorial support for final drafts.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-09 16:17:23 -0500" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-11-09 16:05:48 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-11-09 16:04:35 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Hawkes-1986" MODIFIED="2008-11-09 16:04:22 -0500" MODIFIED_BY="[Empty name]" NAME="Hawkes 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-11-09 16:04:22 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hawkes J, Care G, Dixon JS, Bird HA, Wright VA. Comparison of three different treatments for rheumatoid arthritis of the hands. Physiotherapy Practice 2: 155-160, 1986.&lt;/p&gt;" NOTES_MODIFIED="2008-11-09 16:04:22 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hawkes J, Care G, Dixon JS, Bird HA, Wright VA</AU>
<TI>Comparison of three different treatments for rheumatoid arthritis of the hands</TI>
<SO>Physiotherapy Practice 2</SO>
<YR>1986</YR>
<VL>2</VL>
<PG>155-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Konrad-1994" MODIFIED="2008-11-09 16:04:35 -0500" MODIFIED_BY="[Empty name]" NAME="Konrad 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-11-09 16:04:35 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Konrad K</AU>
<TI>Randomized, Double-Blind, Placebo-Controlled Study of Ultrasonic Treatment of the Hands of Rheumatoid Arthritis Patients</TI>
<SO>European Journal of Physical Medicine and Rehabilitation</SO>
<YR>1994</YR>
<VL>4</VL>
<NO>5</NO>
<PG>155-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="38-EL"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-11-09 16:05:48 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Berliner-1997" MODIFIED="2008-11-09 16:04:45 -0500" MODIFIED_BY="[Empty name]" NAME="Berliner 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-11-09 16:04:45 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berliner M, Piegsa M</AU>
<TI>Effects of Therapeutic Ultrasound in a Water Bath on Skin Microcirculation and Skin Temperature in Rheumatoid Arthritis</TI>
<SO>Europeen Journal of Physical Medicine and Rehabilitation</SO>
<YR>1997</YR>
<VL>7</VL>
<NO>2</NO>
<PG>46-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="31-EL"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bromley-1994" MODIFIED="2008-11-09 16:04:59 -0500" MODIFIED_BY="[Empty name]" NAME="Bromley 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-11-09 16:04:59 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bromley J, Unsworth A, Haslock I</AU>
<TI>Changes in Stiffness Following Short- and Long-term Application of Standard Physiotherapeutic Techniques</TI>
<SO>British Journal of Rheumatology</SO>
<YR>1994</YR>
<VL>33</VL>
<PG>555-61</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="26-EL"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Hadidi-1991" MODIFIED="2008-11-09 16:05:08 -0500" MODIFIED_BY="[Empty name]" NAME="El-Hadidi 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-11-09 16:05:08 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El-Hadidi T, El-Garf A</AU>
<TI>Double-Blind Study Comparing the Use of Voltaren Emulgel versus Regular Gel during Ultrasonic Sessions in the Treatment of Localized Traumatic and Rheumatic Painful Conditions</TI>
<SO>The Journal of International Medical Research</SO>
<YR>1991</YR>
<VL>19</VL>
<PG>219-27</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="30-EL"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herrera_x002d_Lasso-1993" MODIFIED="2008-11-09 16:05:16 -0500" MODIFIED_BY="[Empty name]" NAME="Herrera-Lasso 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-11-09 16:05:16 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herrera-Lasso I, Mobarak L, Fernandez-Dominguez L, Cardiel MH, Alarcon-Segovia D</AU>
<TI>Comparative Effectiveness of Packages of Treatment Including Ultrasound or Transcutaneous Electrical Nerve Stimulation in Painful Shoulder Syndrome</TI>
<SO>Physiotherapy</SO>
<YR>1993</YR>
<VL>79</VL>
<NO>4</NO>
<PG>251-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11-EL"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kitchen-1990" MODIFIED="2008-11-09 15:59:07 -0500" MODIFIED_BY="[Empty name]" NAME="Kitchen 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-11-09 15:59:07 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kitchen SS, Partridge CJ</AU>
<TI>A Review of Therapeutic Ultrasound</TI>
<SO>Physiotherapy</SO>
<YR>1990</YR>
<VL>76</VL>
<NO>10</NO>
<PG>593-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Myyryl_x00e4_inen-1990" NAME="Myyryläinen 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Myyryläinen A, Muhos AL, Mittinen T, Hannonen P</AU>
<TI>A double blind clinical trial of therapeutic ultrasound in the treatment of MTP joints in rheumatoid arthritis</TI>
<SO>Scandinavian Journal of Rheumatology-Suppl</SO>
<YR>1990</YR>
<VL>85</VL>
<PG>17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nykanen-1995" MODIFIED="2008-11-09 16:05:40 -0500" MODIFIED_BY="[Empty name]" NAME="Nykanen 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-11-09 16:05:40 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nykanen M</AU>
<TI>Pulsed Ultrasound Treatment of the Painful Shoulder A Randomized, Double-Blind, Placebo-Controlled Study</TI>
<SO>Scandinavian Journal of Rehabilitation and Medicine</SO>
<YR>1995</YR>
<VL>27</VL>
<PG>105-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Uhlemann-1993" MODIFIED="2008-11-09 16:05:48 -0500" MODIFIED_BY="[Empty name]" NAME="Uhlemann 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-11-09 16:05:48 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uhlemann C</AU>
<TI>Pain modification in rheumatic diseases using different frequency applications of Ultrasound</TI>
<TO>Schmerzanderung bei rheumatischen Krankheiten mittels differenter applikationsfrequnzen des ultraschails</TO>
<SO>Zeitschrift fur Rheumatologie</SO>
<YR>1993</YR>
<VL>52</VL>
<NO>4</NO>
<PG>236-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2008-11-09 16:03:49 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Dorland-1988" MODIFIED="2008-11-09 16:03:49 -0500" MODIFIED_BY="[Empty name]" NAME="Dorland 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-11-09 16:03:49 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Dorland</AU>
<SO>Dorland's illustrated medical dictionnary</SO>
<YR>1988</YR>
<EN>27</EN>
<PB>W Saunders</PB>
<CY>Toronto</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-09 16:17:23 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-09 16:17:23 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-ACR-1996" MODIFIED="2008-11-09 16:13:01 -0500" MODIFIED_BY="[Empty name]" NAME="ACR 1996" TYPE="JOURNAL_ARTICLE">
<AU>ACR: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines</AU>
<TI>Guidelines for the management of Rheumatoid Arthritis</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>1996</YR>
<VL>39</VL>
<PG>713-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Altman-2001" MODIFIED="2008-11-09 16:13:06 -0500" MODIFIED_BY="[Empty name]" NAME="Altman 2001" TYPE="CONFERENCE_PROC">
<AU>Altman D, Elbourne D</AU>
<TI>Incorporating crossover trials into systematic reviews</TI>
<SO>Proceedings of the 9th International Cochrane Colloquium</SO>
<YR>2001</YR>
<PB>Cochrane Collaboration</PB>
<CY>Lyon</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APTA-2001" MODIFIED="2008-11-09 16:13:13 -0500" MODIFIED_BY="[Empty name]" NAME="APTA 2001" TYPE="BOOK">
<AU>American Physical Therapy Association</AU>
<TI>Guide to Physical Therapist Practice: Part One: A Description of Patient/Client Management.</TI>
<SO>APTA</SO>
<YR>2001</YR>
<EN>2nd</EN>
<PB>American Physical Therapy Association</PB>
<CY>Alexandria, Va</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Arnett-1988" MODIFIED="2008-11-09 16:13:18 -0500" MODIFIED_BY="[Empty name]" NAME="Arnett 1988" TYPE="JOURNAL_ARTICLE">
<AU>Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neudstadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG</AU>
<TI>The American Rheumatism Association 1987 Revised Criteria for Classification of Rheumatoid Arthritis</TI>
<SO>Arthritis Rheumatology</SO>
<YR>1988</YR>
<VL>31</VL>
<PG>315-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-BMJ-2001" MODIFIED="2008-11-09 16:13:23 -0500" MODIFIED_BY="[Empty name]" NAME="BMJ 2001" TYPE="BOOK">
<AU>BMJ: BMJ Publishing GroupClinical Evidence</AU>
<SO>A Compendium of the Best Available Evidence for Effective Health Care</SO>
<YR>2001</YR>
<PB>BMJ Publishing Group</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coutts-1994" MODIFIED="2008-11-09 16:13:33 -0500" MODIFIED_BY="[Empty name]" NAME="Coutts 1994" TYPE="BOOK_SECTION">
<AU>Coutts RD, Toth C, Kaita JH</AU>
<TI>The role of continuous passive motion in the rehabilitation of the total knee patient</TI>
<SO>Total Knee Arthroplasty: A Comprehensive Approach</SO>
<YR>1984</YR>
<PG>126-32</PG>
<ED>Hungerford DS, Krackow K, Kenne RV</ED>
<PB>Williams and Wilkins</PB>
<CY>Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deyo-1990" MODIFIED="2008-11-09 16:13:41 -0500" MODIFIED_BY="[Empty name]" NAME="Deyo 1990" TYPE="JOURNAL_ARTICLE">
<AU>Deyo RA, Walsh NE, Schoenfeld LS, Ramamurty S</AU>
<TI>Can trials of physical treatments be blinded: the example of transcutaneous electrical nerve stimulation for chronic pain</TI>
<SO>American Journal of Physical Medicine and Rehabilitation</SO>
<YR>1990</YR>
<VL>69</VL>
<PG>6-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickersin-1994" MODIFIED="2008-11-09 16:08:23 -0500" MODIFIED_BY="[Empty name]" NAME="Dickersin 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dickersin K, Scherer R, Lefebvre C</AU>
<TI>Identifying relevant studies for systematic reviews</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>309</VL>
<PG>1286-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ekdahl-1992" MODIFIED="2008-11-09 16:13:57 -0500" MODIFIED_BY="[Empty name]" NAME="Ekdahl 1992" TYPE="JOURNAL_ARTICLE">
<AU>Ekdahl C, Andersson SI, Ekman R, Svensson B</AU>
<TI>Dynamic training and circulating neuropeptides in rheumatoid arthritis : a two-year follow-up study</TI>
<SO>Pain</SO>
<YR>1992</YR>
<VL>49</VL>
<NO>1</NO>
<PG>61-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ekdahl-1994" MODIFIED="2008-11-09 16:09:15 -0500" MODIFIED_BY="[Empty name]" NAME="Ekdahl 1994" TYPE="JOURNAL_ARTICLE">
<AU>Ekdahl C, Ekdahl R, PeterssonI, Svensson B</AU>
<TI>Dynamic training and circulating neuropeptides in patients with rheumatoid arthritis: a comparative study with health subjects</TI>
<SO>International Journal of Clinical Pharmacology Research</SO>
<YR>1994</YR>
<VL>14</VL>
<NO>2</NO>
<PG>65-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gam-1995" MODIFIED="2008-11-09 16:14:02 -0500" MODIFIED_BY="[Empty name]" NAME="Gam 1995" TYPE="JOURNAL_ARTICLE">
<AU>Gam AN, Johannsen F</AU>
<TI>Ultrasound therapy in musculoskeletal disorders: a meta-analysis</TI>
<SO>Pain</SO>
<YR>1995</YR>
<VL>63</VL>
<PG>85-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haynes-1994" MODIFIED="2008-11-09 16:14:09 -0500" MODIFIED_BY="[Empty name]" NAME="Haynes 1994" TYPE="JOURNAL_ARTICLE">
<AU>Haynes R, Wilczynski N, Mckibbon KA, Walker CJ</AU>
<TI>Developing optimal search strategies for detecting clinically sound studies in MEDLINE</TI>
<SO>Journal of the American Medical Information Association</SO>
<YR>1994</YR>
<VL>1</VL>
<PG>447-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Health-Canada-1987" MODIFIED="2008-11-09 16:14:14 -0500" MODIFIED_BY="[Empty name]" NAME="Health Canada 1987" TYPE="BOOK">
<AU>Health and Welfare Canada</AU>
<SO>Guidelines for safe use of ultrasound, Medical and Paramedical Applications</SO>
<YR>1987</YR>
<VL>Part 1</VL>
<PB>Canadian Government Publishing Center</PB>
<CY>Ottawa</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Helewa-1996" MODIFIED="2008-11-09 16:15:54 -0500" MODIFIED_BY="[Empty name]" NAME="Helewa 1996" TYPE="BOOK_SECTION">
<AU>Helewa A, Walker JM</AU>
<TI>Epidemiology and economics of arthritis</TI>
<SO>Physical therapy in rheumatoid arthritis</SO>
<YR>1996</YR>
<PG>9-18 (Chapter 2)</PG>
<EN>JM Walker &amp; A Helewa (Eds)</EN>
<PB>W.B. Saunders Co</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad A, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ</AU>
<TI>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-1985" MODIFIED="2008-11-09 16:16:20 -0500" MODIFIED_BY="[Empty name]" NAME="Jones 1985" TYPE="JOURNAL_ARTICLE">
<AU>Jones CA, Rees JM, Dodds WN, Jayson MI</AU>
<TI>Changes in plasma opioid concentrations after physiotherapeutic exercises for arthritic patients</TI>
<SO>Neuropeptides</SO>
<YR>1985</YR>
<VL>5</VL>
<NO>4-6</NO>
<PG>561-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lineker-1999" MODIFIED="2008-11-09 16:16:32 -0500" MODIFIED_BY="[Empty name]" NAME="Lineker 1999" TYPE="BOOK">
<AU>Lineker S, Wood H</AU>
<TO>The arthritis Society Consultation and Rehabilitation Services</TO>
<SO>Rheumatoid Arthritis Management Protocol</SO>
<YR>1999</YR>
<PB>The arthritis Society Consultation and Rehabilitation Services</PB>
<CY>Toronto</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Manal-1996" MODIFIED="2008-11-09 16:16:38 -0500" MODIFIED_BY="[Empty name]" NAME="Manal 1996" TYPE="JOURNAL_ARTICLE">
<AU>Manal RJ, Snyder-Mackler L</AU>
<TI>Practice guidelines for anterior cruciate ligament rehabilitation: criterion-based rehabilitation progression</TI>
<SO>Operative Techniques in Orthopaedics</SO>
<YR>1996</YR>
<VL>6</VL>
<PG>190-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morin-1996" MODIFIED="2008-11-09 16:16:44 -0500" MODIFIED_BY="[Empty name]" NAME="Morin 1996" TYPE="CONFERENCE_PROC">
<AU>Morin M, Brosseau L., Quirion-DeGrardi C</AU>
<TI>A theoretical framework on low level laser therapy (classes I, II and III) application for the treatment of OA and RA</TI>
<SO>Proceedings of the Canadian Physiotherapy Association National Congress</SO>
<YR>1996</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-OMERACT-1993" MODIFIED="2008-11-09 16:16:50 -0500" MODIFIED_BY="[Empty name]" NAME="OMERACT 1993" TYPE="JOURNAL_ARTICLE">
<AU>OMERACT</AU>
<TI>Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials</TI>
<SO>Journal of Rheumatology</SO>
<YR>1993</YR>
<VL>20</VL>
<PG>526-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Philadelphia-2001" MODIFIED="2008-11-09 16:16:55 -0500" MODIFIED_BY="[Empty name]" NAME="Philadelphia 2001" TYPE="JOURNAL_ARTICLE">
<AU>The Philadelphia Panel</AU>
<TI>The Philadelphia Panel Evidence-Based Clinical Practice Guidelines on Selected Rehabilitation Interventions for Knee Pain</TI>
<SO>Physical Therapy</SO>
<YR>2001</YR>
<VL>81</VL>
<PG>1675-700</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Puett-1994" MODIFIED="2008-11-09 16:17:04 -0500" MODIFIED_BY="[Empty name]" NAME="Puett 1994" TYPE="JOURNAL_ARTICLE">
<AU>Puett DW, Griffin MR</AU>
<TI>Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1994</YR>
<VL>121</VL>
<NO>2</NO>
<PG>133-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-der-Windt-1999" MODIFIED="2008-11-09 16:17:11 -0500" MODIFIED_BY="[Empty name]" NAME="van der Windt 1999" TYPE="JOURNAL_ARTICLE">
<AU>van der Windt DAWM, van der Heijden GJ, van den Berg SGM, ter Riet G, de Winter AF, Bouter LM</AU>
<TI>Ultrasound for musculoskeletal disorders: a systematic review</TI>
<SO>Pain</SO>
<YR>1999</YR>
<VL>81</VL>
<PG>257-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walker-1996" MODIFIED="2008-11-09 16:17:23 -0500" MODIFIED_BY="[Empty name]" NAME="Walker 1996" TYPE="BOOK">
<AU>Walker JM, Helewa A</AU>
<SO>Physical therapy in Arthritis</SO>
<YR>1996</YR>
<PB>W.B. Saunders Co</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Hawkes-1986">
<CHAR_METHODS>
<P>Randomized study. Sample size at entry for group 1: 10; for group 2: 10; for group 3:10</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients with classical/definite RA disease involved in both hands, pain swelling and limitation of movement</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1- Wax+ exercises;<BR/>2-Ultrasound + exercises;<BR/>3-Ultrasound + faradic + exercises.</P>
<P>US applied in water to the palmar aspect of hand - 0.250W/cm2 continuous, 3MHz, 3min, 5 times/week for 3 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>1- Hand grip (mmHg)<BR/>2- PIP circumference (mm)<BR/>3- Articular Index (0-3)<BR/>4- Pain score (mm)<BR/>5-ROM (mm)<BR/>6- Timed task (sec)<BR/>7- Activity score (checklist)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=1<BR/>B=0<BR/>W=0</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Konrad-1994">
<CHAR_METHODS>
<P>Randomized, placebo-controlled study. Sample size at entry: 50</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>RA (Onset of disease at least 1 yr before; functional class 1 or 2, medium activity of RA -erythrocyte sedimentation rate, C-ractive protein)</P>
<P>Group 1: mean age: 57.3 SD=9<BR/>mean disease duration: 4 SD=1.5</P>
<P>Group 2: mean age: 55.9 SD=8.75<BR/>disease duration: 5 SD=1.75</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment group: US apllied in water to the dorsal and palmar aspects of the hand - 0.05W/cm2 continuous with circular round head, 10min on alternate days for 3 weeks for a total of 10 sessions</P>
<P>Placebo group:<BR/>inactive US in water applied to the palmar and dorsal aspects of the hand</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Change in:<BR/>1-No of painful articulations<BR/>2-No of swollen articulations<BR/>3-Circumference of the PIP joints (mm)<BR/>4- Morning Stiffness (min's)<BR/>5- Dorsal Flexion of the wrist<BR/>-Gripping strength (mmHg)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=1<BR/>B=1<BR/>W=1</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Berliner-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Healthy subjects</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bromley-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixt population (healthy and RA)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-El_x002d_Hadidi-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Measures effect of medication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Herrera_x002d_Lasso-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RA patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kitchen-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Literature review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Myyryl_x00e4_inen-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>no numerical data available/abstract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nykanen-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>No mention of RA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Uhlemann-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>German language</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Dorland-1988">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hawkes-1986">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Konrad-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Treatment vs Placebo (end of treatment -10 weeks)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.9494549639081806" CI_START="0.4505450360918193" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.2" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.0016997552506664917" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="3.1382229683066245">
<NAME>Change in number of painful articulations</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9494549639081806" CI_START="0.4505450360918193" EFFECT_SIZE="1.2" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="0.2" ORDER="145541" SD_1="1.75" SD_2="0.77" SE="0.3823820079449346" STUDY_ID="STD-Konrad-1994" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.5929132634835652" CI_START="0.4470867365164348" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.02" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="4.8398058431125103E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.00000000000001" Z="3.489469334459219">
<NAME>Change in Number of Swollen articulations</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.5929132634835652" CI_START="0.4470867365164348" EFFECT_SIZE="1.02" ESTIMABLE="YES" MEAN_1="1.28" MEAN_2="0.26" ORDER="145542" SD_1="1.35" SD_2="0.56" SE="0.29230805667993487" STUDY_ID="STD-Konrad-1994" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="13.396761409108986" CI_START="-24.796761409108985" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.7" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.5585410548925243" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.5850099120235887">
<NAME>Change in Circumference of the PIP joints (mm)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="13.396761409108986" CI_START="-24.796761409108985" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="6.96" MEAN_2="12.66" ORDER="145543" SD_1="17.41" SD_2="45.5" SE="9.74342465460682" STUDY_ID="STD-Konrad-1994" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.026766657998092E-32" CI_END="56.90391078413965" CI_START="0.1760892158603511" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="28.54" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-001.04" NO="4" P_CHI2="0.0" P_Q="1.0" P_Z="0.048594555828564714" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.9721318595477972">
<NAME>Change in Duration of Morning Stiffness (mins)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="56.903910784139654" CI_START="0.17608921586035464" EFFECT_SIZE="28.540000000000003" ESTIMABLE="YES" MEAN_1="38.2" MEAN_2="9.66" ORDER="145544" SD_1="70.16" SD_2="17.7" SE="14.471648973078361" STUDY_ID="STD-Konrad-1994" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.155160690856955" CI_START="0.6448393091430444" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.9" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.0030082243178099176" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="99.99999999999999" Z="2.966896268941951">
<NAME>Change in Dorsal Flexion of the wrist (degrees)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.155160690856955" CI_START="0.6448393091430444" EFFECT_SIZE="1.9" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="0.5" ORDER="145545" SD_1="3.12" SD_2="0.72" SE="0.6403998750780641" STUDY_ID="STD-Konrad-1994" TOTAL_1="25" TOTAL_2="25" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="42.76922864738175" CI_START="13.370771352618245" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="28.07" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="1.8198520607331533E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="3.742794289810498">
<NAME>Change in Gripping Strength (mmHg)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="42.76922864738175" CI_START="13.370771352618247" EFFECT_SIZE="28.07" ESTIMABLE="YES" MEAN_1="34.4" MEAN_2="6.33" ORDER="145546" SD_1="35.21" SD_2="12.9" SE="7.499744262306549" STUDY_ID="STD-Konrad-1994" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Ultrasound vs Wax (Hand) (End of treatment -1 week)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="253.38014378791542" CI_START="-289.3801437879154" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-18.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965666219607369" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.12999975322178295">
<NAME>Hand grip (mmHg)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="253.38014378791542" CI_START="-289.3801437879154" EFFECT_SIZE="-18.0" ESTIMABLE="YES" MEAN_1="81.0" MEAN_2="99.0" ORDER="145547" SD_1="309.61" SD_2="309.61" SE="138.46180130274197" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="24.152375395834408" CI_START="-36.15237539583441" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668597" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.390011856540661">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="24.152375395834408" CI_START="-36.15237539583441" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="308.0" MEAN_2="314.0" ORDER="145548" SD_1="34.4" SD_2="34.4" SE="15.384147685198553" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.0224741575038125" CI_START="-6.0224741575038125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6963600188246013" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="0.39023873952875915">
<NAME>Articular Index (0-10 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.022474157503813" CI_START="-6.022474157503813" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="11.0" ORDER="145549" SD_1="5.73" SD_2="5.73" SE="2.562533902214759" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="51.22856309375161" CI_START="-39.22856309375161" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="6.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.2600079043604407">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="51.22856309375161" CI_START="-39.22856309375161" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="29.0" MEAN_2="23.0" ORDER="145550" SD_1="51.6" SD_2="51.6" SE="23.076221527797827" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.39961784812865186" CI_START="-0.5996178481286512" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.6948420111966604" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39229262763154066">
<NAME>Activity score (checklist, higher score=better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.39961784812865186" CI_START="-0.5996178481286512" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="7.8" ORDER="145551" SD_1="0.57" SD_2="0.57" SE="0.254911749434976" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Ultrasound vs Wax (Hand) (End of treatment - 2 weeks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="323.22640352774977" CI_START="-369.22640352774977" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-23.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8964070660011362" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13020142653796243">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="323.22640352774977" CI_START="-369.22640352774977" EFFECT_SIZE="-23.0" ESTIMABLE="YES" MEAN_1="88.0" MEAN_2="111.0" ORDER="145552" SD_1="395.0" SD_2="395.0" SE="176.64937022248338" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="20.129901238330596" CI_START="-30.129901238330596" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965613111696634" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.389966511597452">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="20.129901238330596" CI_START="-30.129901238330596" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="305.0" MEAN_2="310.0" ORDER="145553" SD_1="28.67" SD_2="28.67" SE="12.821613782983794" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.0224741575038125" CI_START="-6.0224741575038125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6963600188246013" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="0.39023873952875915">
<NAME>Articular index (0-10 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.022474157503813" CI_START="-6.022474157503813" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" ORDER="145554" SD_1="5.73" SD_2="5.73" SE="2.562533902214759" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="59.76665694271022" CI_START="-45.76665694271022" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.26000790436044063">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="59.76665694271022" CI_START="-45.76665694271022" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="20.0" ORDER="145555" SD_1="60.2" SD_2="60.2" SE="26.92225844909747" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.2076187697917196" CI_START="-1.807618769791721" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.696527780466859" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39001185654066195">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.2076187697917196" CI_START="-1.807618769791721" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="9.1" MEAN_2="9.4" ORDER="145556" SD_1="1.72" SD_2="1.72" SE="0.7692073842599276" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Ultrasound vs Wax (Hand) (End of treatment- 3 weeks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="356.05985869930885" CI_START="-400.05985869930885" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-22.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.9091950528630146" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.11405391677452907">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="356.05985869930885" CI_START="-400.05985869930885" EFFECT_SIZE="-22.0" ESTIMABLE="YES" MEAN_1="89.0" MEAN_2="111.0" ORDER="145557" SD_1="478.41" SD_2="378.41" SE="192.89122743142056" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="24.152375395834408" CI_START="-36.15237539583441" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668597" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.390011856540661">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="24.152375395834408" CI_START="-36.15237539583441" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="304.0" MEAN_2="310.0" ORDER="145558" SD_1="34.4" SD_2="34.4" SE="15.384147685198553" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.0224741575038125" CI_START="-6.0224741575038125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6963600188246013" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="0.39023873952875915">
<NAME>Articular index (0-10, 0 =no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.022474157503813" CI_START="-6.022474157503813" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="6.0" ORDER="145559" SD_1="5.73" SD_2="5.73" SE="2.562533902214759" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.788821751248424" CI_START="-44.78882175124842" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-21.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.08359586764049923" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="1.7301926133933525">
<NAME>ROM (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.788821751248424" CI_START="-44.78882175124842" EFFECT_SIZE="-21.0" ESTIMABLE="YES" MEAN_1="69.0" MEAN_2="90.0" ORDER="145560" SD_1="27.14" SD_2="27.14" SE="12.137376981868858" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="59.76665694271022" CI_START="-45.76665694271022" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.26000790436044063">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="59.76665694271022" CI_START="-45.76665694271022" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="25.0" MEAN_2="18.0" ORDER="145561" SD_1="60.2" SD_2="60.2" SE="26.92225844909747" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.8080009216630695" CI_START="-1.208000921663068" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.6973638922025724" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.38888138739126643">
<NAME>Activity score (checklist, higher score=better)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.8080009216630695" CI_START="-1.208000921663068" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" ORDER="145562" SD_1="1.15" SD_2="1.15" SE="0.5142956348249516" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Ultrasound vs Faradic bath + Ultrasound (Hand) (End of treatment 1 week)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="154.846829902495" CI_START="-176.846829902495" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-11.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965687359089269" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.12999708129854495">
<NAME>Hand grip (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="154.84682990249502" CI_START="-176.84682990249502" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="81.0" MEAN_2="92.0" ORDER="145563" SD_1="189.21" SD_2="189.21" SE="84.61728440454705" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="109.37050893784306" CI_START="-161.37050893784306" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-26.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.7065887753135336" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3764413977452051">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="109.37050893784306" CI_START="-161.37050893784306" EFFECT_SIZE="-26.0" ESTIMABLE="YES" MEAN_1="305.0" MEAN_2="331.0" ORDER="145564" SD_1="154.8" SD_2="154.08" SE="69.06785533082666" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="8.05371354041339" CI_START="-12.05371354041339" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6966115937183786" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3898985139493967">
<NAME>Articular index (0-10 scale, 0=pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.053713540413392" CI_START="-12.053713540413392" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="12.0" ORDER="145565" SD_1="11.47" SD_2="11.47" SE="5.129539940384518" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="68.30475079166882" CI_START="-52.304750791668816" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="8.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.2600079043604407">
<NAME>Time task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="68.30475079166882" CI_START="-52.304750791668816" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="29.0" MEAN_2="21.0" ORDER="145566" SD_1="68.8" SD_2="68.8" SE="30.768295370397105" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.03544305349441079" CI_START="-0.9645569465055874" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.4999999999999991" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.034901610539007595" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.10949809198093">
<NAME>Activity score (checklist, higher score=better)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.03544305349441079" CI_START="-0.9645569465055874" EFFECT_SIZE="-0.4999999999999991" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="8.2" ORDER="145567" SD_1="0.53" SD_2="0.53" SE="0.23702320561497772" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Ultrasound vs Faradic bath +Ultrasound (Hand) (End of treatment-2 weeks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="98.53331388542044" CI_START="-112.53331388542044" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965632998680593" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13000395218022032">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="98.53331388542044" CI_START="-112.53331388542044" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="88.0" MEAN_2="95.0" ORDER="145568" SD_1="120.4" SD_2="120.4" SE="53.84451689819494" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="104.66321512375103" CI_START="-156.66321512375103" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-26.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965342292384706" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3900031355403135">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="104.66321512375103" CI_START="-156.66321512375103" EFFECT_SIZE="-26.0" ESTIMABLE="YES" MEAN_1="305.0" MEAN_2="331.0" ORDER="145569" SD_1="149.07" SD_2="149.07" SE="66.66613068117873" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="12.076187697917204" CI_START="-18.076187697917206" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668597" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.390011856540661">
<NAME>Articular index (0-10 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.076187697917204" CI_START="-18.076187697917206" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="10.0" ORDER="145570" SD_1="17.2" SD_2="17.2" SE="7.692073842599276" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="59.76665694271022" CI_START="-45.76665694271022" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.26000790436044063">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="59.76665694271022" CI_START="-45.76665694271022" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="20.0" ORDER="145571" SD_1="60.2" SD_2="60.2" SE="26.92225844909747" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.01951278701549458" CI_START="-0.5804872129845069" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.036054369667859125" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="2.0963137289060576">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.01951278701549458" CI_START="-0.5804872129845069" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="9.1" MEAN_2="9.4" ORDER="145572" SD_1="0.32" SD_2="0.32" SE="0.14310835055998655" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Ultrasound vs Faradic bath +Ultrasound (Hand)(End of treatment-3 weeks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="140.7706422045778" CI_START="-160.7706422045778" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-10.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965692794816777" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.12999639425032206">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="140.7706422045778" CI_START="-160.7706422045778" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="89.0" MEAN_2="99.0" ORDER="145573" SD_1="172.01" SD_2="172.01" SE="76.92521056194776" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="100.64074096624722" CI_START="-150.64074096624722" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-25.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965411936125214" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3899937172979959">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="100.64074096624722" CI_START="-150.64074096624722" EFFECT_SIZE="-25.0" ESTIMABLE="YES" MEAN_1="304.0" MEAN_2="329.0" ORDER="145574" SD_1="143.34" SD_2="143.34" SE="64.10359677896398" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="20.129901238330596" CI_START="-30.129901238330596" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965613111696634" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.389966511597452">
<NAME>Articular Index (0-10 scale, 0=pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="20.129901238330596" CI_START="-30.129901238330596" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="10.0" ORDER="145575" SD_1="28.67" SD_2="28.67" SE="12.821613782983794" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="42.690469244793015" CI_START="-32.690469244793015" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.26000790436044063">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="42.690469244793015" CI_START="-32.690469244793015" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="25.0" MEAN_2="20.0" ORDER="145576" SD_1="43.0" SD_2="43.0" SE="19.23018460649819" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.5096011059956833" CI_START="0.09039889400431811" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.3000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.035166076183242655" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.1064408483693686">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.5096011059956833" CI_START="0.09039889400431811" EFFECT_SIZE="1.3000000000000007" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="8.7" ORDER="145577" SD_1="1.38" SD_2="1.38" SE="0.6171547617899419" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.063243069561853" CI_START="-17.063243069561853" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-8.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.08362433451904365" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="1.7300332514505143">
<NAME>ROM (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.063243069561853" CI_START="-17.063243069561853" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="69.0" MEAN_2="77.0" ORDER="145578" SD_1="10.34" SD_2="10.34" SE="4.624188577469565" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>Faradic bath +Ultrasound vs Wax (Hand) (End of treatment-1 week)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="98.53331388542044" CI_START="-112.53331388542044" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965632998680593" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13000395218022032">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="98.53331388542044" CI_START="-112.53331388542044" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="92.0" MEAN_2="99.0" ORDER="145579" SD_1="120.4" SD_2="120.4" SE="53.84451689819494" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="126.53331388542044" CI_START="-84.53331388542044" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="21.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668598" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39001185654066095">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="126.53331388542044" CI_START="-84.53331388542044" EFFECT_SIZE="21.0" ESTIMABLE="YES" MEAN_1="335.0" MEAN_2="314.0" ORDER="145580" SD_1="120.4" SD_2="120.4" SE="53.84451689819494" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.0224741575038125" CI_START="-4.0224741575038125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6963600188246013" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="0.39023873952875915">
<NAME>Articular index (0-10 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.022474157503813" CI_START="-4.022474157503813" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="11.0" ORDER="145581" SD_1="5.73" SD_2="5.73" SE="2.562533902214759" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="13.076187697917204" CI_START="-17.076187697917206" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.2600079043604407">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="13.076187697917204" CI_START="-17.076187697917206" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="23.0" ORDER="145582" SD_1="17.2" SD_2="17.2" SE="7.692073842599276" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.7769046924479295" CI_START="0.0230953075520694" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.39999999999999947" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.037519733212751476" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.0800632348835224">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.7769046924479295" CI_START="0.0230953075520694" EFFECT_SIZE="0.39999999999999947" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="7.8" ORDER="145583" SD_1="0.43" SD_2="0.43" SE="0.1923018460649819" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" NO="9">
<NAME>Faradic bath +Ultrasound vs Wax (Hand)(End of treatment - 2 weeks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="225.22776839208103" CI_START="-257.22776839208103" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-16.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965670372073602" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.12999922837104988">
<NAME>Hand Grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="225.22776839208103" CI_START="-257.22776839208103" EFFECT_SIZE="-16.0" ESTIMABLE="YES" MEAN_1="95.0" MEAN_2="111.0" ORDER="145584" SD_1="275.21" SD_2="275.21" SE="123.07765361754342" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="126.53331388542044" CI_START="-84.53331388542044" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="21.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668598" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39001185654066095">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="126.53331388542044" CI_START="-84.53331388542044" EFFECT_SIZE="21.0" ESTIMABLE="YES" MEAN_1="331.0" MEAN_2="310.0" ORDER="145585" SD_1="120.4" SD_2="120.4" SE="53.84451689819494" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="12.05371354041339" CI_START="-8.05371354041339" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6966115937183786" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3898985139493967">
<NAME>Articular index (0-10 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.053713540413392" CI_START="-8.053713540413392" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="8.0" ORDER="145586" SD_1="11.47" SD_2="11.47" SE="5.129539940384518" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="20.0" MEAN_2="20.0" ORDER="145587" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="9.4" MEAN_2="9.4" ORDER="145588" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" NO="10">
<NAME>Faradic bath + Ultrasound vs Wax (Hand) (End of treatment - 3 weeks)*</NAME>
<CONT_OUTCOME CHI2="3.71788531068438E-34" CI_END="168.56364335877583" CI_START="-192.56364335877583" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-11.999999999999998" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-010.01" NO="1" P_CHI2="0.0" P_Q="1.0" P_Z="0.8963635841505456" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13025638703882267">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="168.56364335877583" CI_START="-192.56364335877583" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="99.0" MEAN_2="111.0" ORDER="145589" SD_1="206.0" SD_2="206.0" SE="92.12600067299134" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="114.48836557041281" CI_START="-76.48836557041281" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="19.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965454291032337" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3899879894666422">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="114.48836557041281" CI_START="-76.48836557041281" EFFECT_SIZE="19.0" ESTIMABLE="YES" MEAN_1="329.0" MEAN_2="310.0" ORDER="145590" SD_1="108.94" SD_2="108.94" SE="48.71944909376542" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="24.098661855421017" CI_START="-16.098661855421017" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="4.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6964858569552868" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3900685525512062">
<NAME>Articular index (0-10 scale, 0 no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="24.098661855421017" CI_START="-16.098661855421017" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="6.0" ORDER="145591" SD_1="22.93" SD_2="22.93" SE="10.254607744814036" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="17.076187697917206" CI_START="-13.076187697917204" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.2600079043604407">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="17.076187697917206" CI_START="-13.076187697917204" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="18.0" ORDER="145592" SD_1="17.2" SD_2="17.2" SE="7.692073842599276" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.629649721936177E-32" CI_END="-0.09756393507746886" CI_START="-2.9024360649225307" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4999999999999998" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-010.05" NO="5" P_CHI2="0.0" P_Q="1.0" P_Z="0.0360543696678596" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.0963137289060523">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.09756393507746908" CI_START="-2.902436064922531" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="10.2" ORDER="145593" SD_1="1.6" SD_2="1.6" SE="0.7155417527999328" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.7255786816865708" CI_START="-27.72557868168657" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-13.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.08357835085621296" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="1.7302906968748373">
<NAME>ROM (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.7255786816865708" CI_START="-27.72557868168657" EFFECT_SIZE="-13.0" ESTIMABLE="YES" MEAN_1="77.0" MEAN_2="90.0" ORDER="145594" SD_1="16.8" SD_2="16.8" SE="7.513188404399293" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-09 15:54:57 -0500" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-11-09 15:54:57 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-09 15:54:55 -0500" MODIFIED_BY="[Empty name]">Full search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-09 15:54:57 -0500" MODIFIED_BY="[Empty name]">
<P>1 exp osteoarthritis/<BR/>2 osteoarthritis.tw.<BR/>3 osteoarthrosis.tw.<BR/>4 degenerative arthritis.tw.<BR/>5 exp arthritis, rheumatoid/<BR/>6 rheumatoid arthritis.tw.<BR/>7 rheumatism.tw.<BR/>8 arthritis, juvenile rheumatoid/<BR/>9 caplan's syndrome.tw.<BR/>10 felty's syndrome.tw.<BR/>11 rheumatoid.tw.<BR/>12 ankylosing spondylitis.tw.<BR/>13 arthrosis.tw.<BR/>14 sjogren$.tw.<BR/>15 or/1-14<BR/>16 heat/tu<BR/>17 (heat or hot or ice).tw.<BR/>18 cryotherapy.sh,tw.<BR/>19 (vapocoolant or phonophoresis).tw.<BR/>20 exp hyperthermia, induced/<BR/>21 (hypertherm$ or thermotherapy).tw.<BR/>22 (fluidotherapy or compression).tw.<BR/>23 15 and 22<BR/>24 clinical trial.pt.<BR/>25 randomized controlled trial.pt.<BR/>26 tu.fs.<BR/>27 dt.fs.<BR/>28 random$.tw.<BR/>29 placebo$.tw.<BR/>30 ((sing$ or doubl$ or tripl$) adj (masked or blind$)).tw<BR/>31 sham.tw.<BR/>32 or/24-31<BR/>33 23 and 32</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>